← Open Payments lookup

TAYLOR POPP: Open Payments

NPI 1821600982 · WASHINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$187 in 11 payments from 7 companies in 2025. Trend: 2023 $94 · 2024 $112 · 2025 $187

Food & beverage: $187
CompanyPaymentsAmount
ABBVIE INC.3$54
Lilly USA, LLC2$32
Novartis Pharmaceuticals Corporation2$32
Novo Nordisk Inc1$21
AstraZeneca Pharmaceuticals LP1$20
Corium, LLC1$14
Takeda Pharmaceuticals U.S.A., Inc.1$14

Products named: VRAYLAR, LEQVIO, Ozempic, BREZTRI, ZEPBOUND, QULIPTA, MOUNJARO, Azstarys.

Industry payments across IN — which companies pay providers there.